Collaborative Practice Agreement · PharmD
Kansas Written Collaborative Practice Agreement for Pharmacists
Required. The Written Collaborative Practice Agreement is the written instrument Kansas law names for a Pharmacist working with a physician. Below: the board that governs it, what it must contain, and the terms it has to carry.
Represents Kansas's optional pharmacist-physician Collaborative Practice Agreement (CPA) tier for collaborative drug therapy management, not ordinary pharmacist licensure — base dispensing needs no agreement. The collaborating physician remains responsible for the patient's care and for directing/supervising the pharmacist; the pharmacist may not diagnose, alter the physician's orders, or independently prescribe.
What a Kansas Written Collaborative Practice Agreement must contain
Governed by the Kansas State Board of Pharmacy. Each numbered item is a statutory requirement the agreement must satisfy.
Kansas does not require the Pharmacist to hold a collaborative practice agreement in order to practice pharmacy generally. To engage in collaborative drug therapy management for a specific patient, however, the Pharmacist and the Physician shall enter into a written collaborative practice agreement, as authorized by K.S.A. 65-1626a. The agreement shall set out the conditions or limitations under which services are delegated to the Pharmacist pursuant to the Physician's order, standing order, delegation, or protocol, and shall be consistent with the Physician's normal and customary specialty, competence, and lawful practice, and appropriate to the Pharmacist's training and experience.
The Physician retains responsibility for the patient's care, including the initial diagnosis, assessment, direction, and supervision of the Pharmacist's delegated functions. This Agreement's terms regarding the Pharmacist accordingly define the working relationship and communication expectations between the Parties, and are not themselves required by Kansas law unless the Pharmacist engages in collaborative drug therapy management.
- The Written Collaborative Practice Agreement on file also carries 1 scope, 1 education, 1 registration clauses, generated in the document itself.
Statutes and rules cited
- K.S.A. 65-1626astatute
Defines a collaborative practice agreement / collaborative drug therapy management between one or more pharmacists and physicians, and sets the conditions under which a physician may delegate pharmaceutical patient care functions to a pharmacist.
Terms it has to carry
Ratio, proximity, chart review, meeting and prescribing terms the agreement has to carry, from the state's supervision rules.
Proximity
Not codified — left to the agreement
Supervision ratio
Not codified — no cap on file
Chart review
Not codified — left to the agreement
Meeting cadence
Not codified — left to the agreement
Prescriptive authority
Covered by the practice agreement · no controlled-substance authority
Under a CPA, the pharmacist performs delegated drug-therapy management per the collaborating physician's order/standing order/protocol (K.S.A. 65-1626a; K.A.R. 68-7-22) — not independent DEA-registered controlled-substance prescribing. May not diagnose/treat disease, alter physician orders, or independently prescribe. Whether CPA terms may extend to controlled substances was not confirmed in this pass.
Written agreement
Required
Only required if the pharmacist and physician elect to engage in collaborative drug therapy management — a pharmacist's base license and general dispensing authority need no agreement at all (K.S.A. 65-1626a; K.A.R. 68-7-22).
Practice ownership (corporate practice of medicine)
Non-licensee ownership permitted — No pharmacist-ownership requirement was identified for Kansas pharmacy permits in this pass — not independently confirmed against a specific statute/reg; treat as consistent with the typical non-restrictive pharmacy-ownership pattern seen in other states rather than a settled Kansas-specific finding.
Materially more permissive than the healing-arts CPOM regime governing PA/APRN entities above, if confirmed.
About Kansas's rules
Senate Sub. for H.B. 2279 (eff. July 1, 2022) made Kansas a full-practice-authority state for all APRN categories (NP/PMHNP/CRNA/CNM/CNS) — no collaborative practice agreement, supervising physician, or prescribing protocol is required, with no experience threshold. The Kansas Medical Society has publicly disputed how far Board of Nursing regulations implementing this reform extend, calling some language an unauthorized expansion into medical practice — an unresolved legal/political dispute, not settled law. PAs are unaffected by this reform and remain supervised.
Other clinicians in Kansas: see the state overview.